UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 161

Sortiert nach

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling

Nature communications, 2021-03, Vol.12 (1), p.1858-1858, Article 1858

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

Cell reports (Cambridge), 2021-05, Vol.35 (5), p.109071-109071, Article 109071

2021

Link zum Volltext

Verfügbarkeit prüfen

Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice

Frontiers in oncology, 2022-10, Vol.12, p.1021057-1021057

2022

Link zum Volltext

Verfügbarkeit prüfen

Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer

Frontiers in immunology, 2019-07, Vol.10, p.1767-1767

2019

Link zum Volltext

Verfügbarkeit prüfen

Surveillance strategies in the follow-up of melanoma patients: too much or not enough?

The Journal of surgical research, 2017-06, Vol.214, p.32-37

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002203

2021

Link zum Volltext

Verfügbarkeit prüfen

Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes

Annals of surgical oncology, 2020-12, Vol.27 (13), p.4870-4871

Beasley, Georgia M.

2020

Link zum Volltext

Verfügbarkeit prüfen

Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma

Annals of surgical oncology, 2020-09, Vol.27 (9), p.3121-3122

Beasley, Georgia M.

2020

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic viruses in melanoma

Frontiers in bioscience (Landmark. Print), 2022-02, Vol.27 (2), p.63-63

2022

Link zum Volltext

Verfügbarkeit prüfen

Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis

Frontiers in immunology, 2022-08, Vol.13, p.952220-952220

2022

Link zum Volltext

Verfügbarkeit prüfen

Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms

Frontiers in immunology, 2023, Vol.14, p.1116034-1116034

2023

Link zum Volltext

Verfügbarkeit prüfen

Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution

Journal of the American College of Surgeons, 2011-08, Vol.213 (2), p.306

2011

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors of neoadjuvant immune checkpoint blockade in melanoma

Human vaccines & immunotherapeutics, 2022-05, Vol.18 (3), p.1943987-1943987

2022

Link zum Volltext

Verfügbarkeit prüfen

Prospective Multicenter Phase II Trial of Systemic ADH-1 in Combination With Melphalan via Isolated Limb Infusion in Patients With Advanced Extremity Melanoma

Journal of clinical oncology, 2011-03, Vol.29 (9), p.1210-1215

2011

Link zum Volltext

Verfügbarkeit prüfen

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US

Journal of the American College of Surgeons, 2009-05, Vol.208 (5), p.706

2009

Link zum Volltext

Verfügbarkeit prüfen

Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis

Cancer control, 2021, Vol.28, p.10732748211053567-10732748211053567

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma

Journal of the American College of Surgeons, 2014-04, Vol.218 (4), p.686

2014

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival Improved for Contemporary Patients with Melanoma: A 2004–2015 National Cancer Database Analysis

Oncology and therapy, 2020-12, Vol.8 (2), p.261-275

2020

Link zum Volltext

Verfügbarkeit prüfen

Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils

Journal for immunotherapy of cancer, 2023-04, Vol.11 (4), p.e006463

2023

Link zum Volltext

Verfügbarkeit prüfen

Articles from 2022 to 2023 to Inform Your Cancer Practice: Melanoma

Annals of surgical oncology, 2024-03, Vol.31 (3), p.1851-1856

2024

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma

Clinical cancer research, 2012-06, Vol.18 (12), p.3328-3339

2012

Link zum Volltext

Verfügbarkeit prüfen

ASO Author Reflections: It’s About Time?

Annals of surgical oncology, 2023-10, Vol.30 (11), p.6353-6354

2023

Link zum Volltext

Verfügbarkeit prüfen

Type of Organ Transplanted Impacts the Risk and Presentation of Cutaneous Squamous Cell Carcinoma in Transplant Recipients

Experimental and clinical transplantation, 2020-02, Vol.18 (1), p.93-97

2020

Link zum Volltext

Verfügbarkeit prüfen

Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma

Journal for immunotherapy of cancer, 2022-09, Vol.10 (9), p.e005052

2022

Link zum Volltext

Verfügbarkeit prüfen

ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma

Annals of surgical oncology, 2021-07, Vol.28 (7), p.3511-3511

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(144)

Publikationsform

Artikel
(155)
Buchkapitel
(6)

Sprache

Englisch
(161)
Japanisch
(6)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice

Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer

Surveillance strategies in the follow-up of melanoma patients: too much or not enough?

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes

Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma

Oncolytic viruses in melanoma

Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis

Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms

Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution

Predictive factors of neoadjuvant immune checkpoint blockade in melanoma

Prospective Multicenter Phase II Trial of Systemic ADH-1 in Combination With Melphalan via Isolated Limb Infusion in Patients With Advanced Extremity Melanoma

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US

Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis

Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma

Overall Survival Improved for Contemporary Patients with Melanoma: A 2004–2015 National Cancer Database Analysis

Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils

Articles from 2022 to 2023 to Inform Your Cancer Practice: Melanoma

Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma

ASO Author Reflections: It’s About Time?

Type of Organ Transplanted Impacts the Risk and Presentation of Cutaneous Squamous Cell Carcinoma in Transplant Recipients

Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma

ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma

Suchergebnisse filtern